Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA grants RMAT designation to SanBio’s cell therapy

pharmaceutical-technologySeptember 25, 2019

Tag: FDA , RMAT , SanBio , SB623

PharmaSources Customer Service